Adolor Suffers Setback On FDA Request For More Entereg Data Nov. 7, 2006 By Aaron Lorenzo No Comments The FDA delayed approving Adolor Corp.'s Entereg (alvimopan) for postoperative ileus yet again, pending additional safety data, causing the company's shares to tumble by 44.8 percent on Monday. (BioWorld Today)Read More
Disparate voices, no consensus on UDI benefits and difficulties Nov. 2, 2006 By Aaron Lorenzo No Comments
